Short-Read Sequencing

Global Market Trajectory & Analytics

MCP22761

EXECUTIVE ENGAGEMENTS

POOL

907
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

181
Interactions with Platform & by Email

PARTICIPANTS

36
Unique # Participated

VALIDATIONS

12
Responses Validated*

COMPANIES

32
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

104

PAGES

166

EDITION

6

PRICE

USD 5600

CODE

MCP22761


COMPETITIVE METRICS

COMPANY

D S N T

% *

Loop Genomics

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Short-Read Sequencing estimated at US$10.6 Billion in the year 2020, is projected to reach a revised size of US$20.4 Billion by 2027, growing at aCAGR of 9.9% over the period 2020-2027. Next-Generation Sequencing, one of the segments analyzed in the report, is projected to record 9.5% CAGR and reach US$13.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sanger Sequencing segment is readjusted to a revised 10.6% CAGR for the next 7-year period.
The Short-Read Sequencing market in the U.S. is estimated at US$3.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.5 Billion by the year 2027 trailing a CAGR of 9.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.1% and 8.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

SELECT PLAYERS

10x Genomics; Agilent Technologies, Inc.; BGI; Eurofins Scientific; F. Hoffmann-La Roche Ltd; Fasteris; General Electric; Genewiz; GenScript; Illumina, Inc; Macrogen, Inc; Qiagen; Thermo Fisher Scientific, Inc.

SEGMENTS

» Technology (Next-Generation Sequencing, Sanger Sequencing) » Product (Consumables, Instruments, Services) » End-Use (Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities, Other End-Uses)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Short-Read Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Short-Read Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for Next-Generation Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Next-Generation Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Sanger Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Sanger Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Academic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Pharma & Biotech Entities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Pharma & Biotech Entities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Short-Read Sequencing by Technology - Next-Generation Sequencing and Sanger Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Short-Read Sequencing by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing and Sanger Sequencing for the Years 2020 & 2027
USA Current & Future Analysis for Short-Read Sequencing by End-Use - Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Short-Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities for the Years 2020 & 2027
USA Current & Future Analysis for Short-Read Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Short-Read Sequencing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2020 & 2027
CANADA
Canada Current & Future Analysis for Short-Read Sequencing by Technology - Next-Generation Sequencing and Sanger Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Short-Read Sequencing by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing and Sanger Sequencing for the Years 2020 & 2027
Canada Current & Future Analysis for Short-Read Sequencing by End-Use - Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Short-Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities for the Years 2020 & 2027
Canada Current & Future Analysis for Short-Read Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Short-Read Sequencing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2020 & 2027
JAPAN
Japan Current & Future Analysis for Short-Read Sequencing by Technology - Next-Generation Sequencing and Sanger Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Short-Read Sequencing by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing and Sanger Sequencing for the Years 2020 & 2027
Japan Current & Future Analysis for Short-Read Sequencing by End-Use - Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Short-Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities for the Years 2020 & 2027
Japan Current & Future Analysis for Short-Read Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Short-Read Sequencing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2020 & 2027
CHINA
China Current & Future Analysis for Short-Read Sequencing by Technology - Next-Generation Sequencing and Sanger Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Short-Read Sequencing by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing and Sanger Sequencing for the Years 2020 & 2027
China Current & Future Analysis for Short-Read Sequencing by End-Use - Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Short-Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities for the Years 2020 & 2027
China Current & Future Analysis for Short-Read Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Short-Read Sequencing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for Short-Read Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Short-Read Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Europe Current & Future Analysis for Short-Read Sequencing by Technology - Next-Generation Sequencing and Sanger Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Short-Read Sequencing by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing and Sanger Sequencing for the Years 2020 & 2027
Europe Current & Future Analysis for Short-Read Sequencing by End-Use - Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Short-Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities for the Years 2020 & 2027
Europe Current & Future Analysis for Short-Read Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Short-Read Sequencing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2020 & 2027
FRANCE
France Current & Future Analysis for Short-Read Sequencing by Technology - Next-Generation Sequencing and Sanger Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Short-Read Sequencing by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing and Sanger Sequencing for the Years 2020 & 2027
France Current & Future Analysis for Short-Read Sequencing by End-Use - Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Short-Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities for the Years 2020 & 2027
France Current & Future Analysis for Short-Read Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Short-Read Sequencing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2020 & 2027
GERMANY
Germany Current & Future Analysis for Short-Read Sequencing by Technology - Next-Generation Sequencing and Sanger Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Short-Read Sequencing by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing and Sanger Sequencing for the Years 2020 & 2027
Germany Current & Future Analysis for Short-Read Sequencing by End-Use - Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Short-Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities for the Years 2020 & 2027
Germany Current & Future Analysis for Short-Read Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Short-Read Sequencing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2020 & 2027
ITALY
Italy Current & Future Analysis for Short-Read Sequencing by Technology - Next-Generation Sequencing and Sanger Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Short-Read Sequencing by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing and Sanger Sequencing for the Years 2020 & 2027
Italy Current & Future Analysis for Short-Read Sequencing by End-Use - Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Short-Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities for the Years 2020 & 2027
Italy Current & Future Analysis for Short-Read Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Short-Read Sequencing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Short-Read Sequencing by Technology - Next-Generation Sequencing and Sanger Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Short-Read Sequencing by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing and Sanger Sequencing for the Years 2020 & 2027
UK Current & Future Analysis for Short-Read Sequencing by End-Use - Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Short-Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities for the Years 2020 & 2027
UK Current & Future Analysis for Short-Read Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Short-Read Sequencing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Short-Read Sequencing by Technology - Next-Generation Sequencing and Sanger Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Short-Read Sequencing by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing and Sanger Sequencing for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Short-Read Sequencing by End-Use - Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Short-Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Short-Read Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Short-Read Sequencing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Short-Read Sequencing by Technology - Next-Generation Sequencing and Sanger Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Short-Read Sequencing by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing and Sanger Sequencing for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Short-Read Sequencing by End-Use - Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Short-Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Short-Read Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Short-Read Sequencing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Short-Read Sequencing by Technology - Next-Generation Sequencing and Sanger Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Short-Read Sequencing by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing and Sanger Sequencing for the Years 2020 & 2027
Rest of World Current & Future Analysis for Short-Read Sequencing by End-Use - Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Short-Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Academic Research, Clinical Research, Hospitals & Clinics and Pharma & Biotech Entities for the Years 2020 & 2027
Rest of World Current & Future Analysis for Short-Read Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Short-Read Sequencing by Product - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2020 & 2027
Total Companies Profiled: 32

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com